Panacea Life Sciences Holdings, Inc. (PLSH)

PLSH Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-8.02	-11.1	-6.12	-6.99	-9.48
Depreciation & Amortization	1.71	1.73	0.97	0.34	0.89
Other Operating Activities	4.78	6.97	1.24	-1	2.84
Operating Cash Flow	-1.52	-2.4	-3.92	-7.65	-5.75
Capital Expenditures	-0.07	-0.24	-0.16	-3.2	-0.54
Acquisitions	0	0	0.01	0.12	-1.5
Change in Investments	-	-0.05	-0.45	2.96	-
Other Investing Activities	-	0.09	1.12	-2.96	0
Investing Cash Flow	-0.07	-0.2	0.52	-3.08	-2.04
Common Stock Issued	0	0.06	4.37	0.39	7.22
Share Repurchases	0	0	0	0	1.44
Other Financing Activities	1.68	2.53	-1.03	1.91	2.03
Financing Cash Flow	1.68	2.58	3.33	2.3	7.8
Net Cash Flow	0.09	-0.01	-0.06	-8.43	0.02
Free Cash Flow	-1.59	-2.64	-4.09	-10.85	-6.29
Free Cash Flow Margin	-66.66%	-162.47%	-198.34%	-120.28%	-1818.88%
Free Cash Flow Per Share	-0.10	-0.18	-0.23	-0.64	-5.19

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.